{
    "id": "correct_subsidiary_00135_0",
    "rank": 94,
    "data": {
        "url": "https://www.innoplexus.com/news-media/",
        "read_more_link": "",
        "language": "en",
        "title": "News & Media",
        "top_image": "https://www.innoplexus.com/wp-content/uploads/2022/03/fevicon.png",
        "meta_img": "https://www.innoplexus.com/wp-content/uploads/2022/03/fevicon.png",
        "images": [
            "https://www.innoplexus.com/wp-content/uploads/2022/10/Loudspeaker-icon.png",
            "https://www.innoplexus.com/wp-content/uploads/2022/04/Innoplexus-DrD-partnership-150x150.jpeg",
            "https://www.innoplexus.com/wp-content/uploads/2024/06/Partex-EDCC-collaboration-illustration.png",
            "https://www.innoplexus.com/wp-content/uploads/2024/04/Partex-Lupin-press-release-illustration.png",
            "https://www.innoplexus.com/wp-content/uploads/2023/06/horizon-awards-gold-winner.png",
            "https://www.innoplexus.com/wp-content/uploads/2023/04/Innoplexus-logo-220x57.png",
            "https://www.innoplexus.com/wp-content/uploads/2023/04/Innoplexus-logo-220x57.png",
            "https://www.innoplexus.com/wp-content/uploads/2024/06/Partex-EDCC-collaboration-illustration.png",
            "https://www.innoplexus.com/wp-content/uploads/2024/04/Partex-Lupin-press-release-illustration.png",
            "https://www.innoplexus.com/wp-content/uploads/2024/03/Partex-NV-announces-collaboration-with-Althea-DRF-Lifesciences.png",
            "https://www.innoplexus.com/wp-content/uploads/2024/03/Partex-Group-presents-results-from-a-pilot-project-with-AIO.png",
            "https://www.innoplexus.com/wp-content/uploads/2024/03/Partex-Sanofi-press-release-illustration.png",
            "https://www.innoplexus.com/wp-content/uploads/2024/01/Innoplexus-AIO-partnership.png",
            "https://www.innoplexus.com/wp-content/uploads/2023/06/anavex_partex_partnership_Innoplexus.png",
            "https://www.innoplexus.com/wp-content/uploads/2023/02/Kittu-Press-Release-1.webp",
            "https://www.innoplexus.com/wp-content/uploads/2022/08/Bad-hearsfeld.jpg",
            "https://www.innoplexus.com/wp-content/uploads/2022/08/Innoplexus-Innovatrix-partnership.jpg",
            "https://www.innoplexus.com/wp-content/uploads/2022/06/Innoplexus-inflection-biosciences-joint-pr.png",
            "https://www.innoplexus.com/wp-content/uploads/2022/04/Innoplexus-Parexel-Expand-Capabilities.jpeg",
            "https://www.innoplexus.com/wp-content/uploads/2022/04/parexel_clearinghouse.jpeg",
            "https://www.innoplexus.com/wp-content/uploads/2022/04/google_pharma_industry.jpeg",
            "https://www.innoplexus.com/wp-content/uploads/2022/04/pharma_visionary.jpeg",
            "https://www.innoplexus.com/wp-content/uploads/2022/04/Hessen-funds-research-project.png",
            "https://www.innoplexus.com/wp-content/uploads/2022/04/new_app_cancer_patients.jpeg",
            "https://www.innoplexus.com/wp-content/uploads/2022/04/role_of_AI_soars_in_tackling_covid-19.jpeg",
            "https://www.innoplexus.com/wp-content/uploads/2022/04/Combination-Therapies-for-covid-19.jpeg",
            "https://www.innoplexus.com/wp-content/uploads/2022/04/Edison_Awards_Winner.jpeg",
            "https://www.innoplexus.com/wp-content/uploads/2022/04/steps-to-combat-the-coronavirus.jpeg",
            "https://www.innoplexus.com/wp-content/uploads/2022/04/COVID-19-research.jpeg",
            "https://www.innoplexus.com/wp-content/uploads/2022/04/New-Employee-Joining.jpeg",
            "https://www.innoplexus.com/wp-content/uploads/2022/04/ISO-IEC-27001-2013-certification.jpeg",
            "https://www.innoplexus.com/wp-content/uploads/2022/04/catana-pr.jpeg",
            "https://www.innoplexus.com/wp-content/uploads/2022/04/Innoplexus-and-Wiley-partnership.jpeg",
            "https://www.innoplexus.com/wp-content/uploads/2022/04/Cutting-Edge-Chemistry.jpeg",
            "https://www.innoplexus.com/wp-content/uploads/2019/09/New-Employee-Joining.jpg",
            "https://www.innoplexus.com/wp-content/uploads/2019/09/Innoplexus_Bilanz.jpg",
            "https://www.innoplexus.com/wp-content/uploads/2019/09/New-Employee-Joining.jpg",
            "https://www.innoplexus.com/wp-content/uploads/2019/08/Cures-Within-Reach.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/06/pharmaceutical-technology.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/06/predicting-drug-flops.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/06/google-healthcare.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/06/automotive_news.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/05/Academic-Access-Program.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/05/deutscher.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/05/Image-6.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/05/Handelsblatt0.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/05/gunjan-bilanz.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/05/reflex-verlag.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/05/handelsblatt.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/05/Advantage-of-AI-and-Deep-Tech.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/05/pioniere-der-naechsten.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/05/INNOPLEXUS-WIEDER-IM-GARTNER-HYPE-CYCLE-FÜR-LIFE-SCIENCES.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/05/welt-de.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/05/How-can-AI-be-leveraged-for-Clinical-Trial-Prediction.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/04/ai-life-sciences.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/04/CTP-press-release.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/04/predicts-costly-pharma-flops-.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/03/nVidia-GTC.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/03/pharma-healthcare-analytics.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/02/data-network.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/02/pulse-in-healthcare1.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/05/Handelsblatt0.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/01/cphi.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/01/Image-5.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/01/Image-1.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/01/Image-2.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/01/Image-3.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/01/INNOPLEXUS-INCLUDED-AGAIN-IN-GARTNER-HYPE-CYCLE-FOR-LIFE-SCIENCES.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/01/ted.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/01/ted.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/01/aI-improvements-pharma-manufacturing.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/12/disruptor.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/12/5-Predictions-for-AI-in-2019.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/11/ai-healthcare.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/11/cio-review.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/05/handelsblatt.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/10/korea-conference-2018.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/05/gunjan-bilanz.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/05/reflex-verlag.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/09/artificial-intelligence.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/09/transparency-would-bolster.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/08/Image-7.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/08/aI-blockchain.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/08/disruptor-that-pharma.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/08/blockchain-and-pharma-innovation.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/07/coinstaker.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/07/inside-bigdata1.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/07/blockchain-is-dream.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/07/iStock-8664337601-840x470-1.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/07/blockchain-pharma-companies-1.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/07/Image-8.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/07/Image-9.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/07/tech-bullion1.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/07/oracle-times.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/07/24x7pressrelease.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/07/beyond-competition.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/07/Image-10.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/07/artificial.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/06/med-ad-news1.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/06/advertising.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/06/blockchain-technology-1.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/06/big-data.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/06/ai-and-blockchain-1-min.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/06/unlock-innovation-1.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/07/blockchain-is-dream.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/05/blockchain-platform.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/05/blockchain.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/05/german-blockchain.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/05/nvidia.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/05/is-open-data.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/05/media-design.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/05/blockchain-leverages.svg",
            "https://www.innoplexus.com/wp-content/uploads/2019/03/innoplexus’s-new-north-american.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/05/innoplexus-releases.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/05/esslli2018.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/05/new-north-american.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/05/innoplexus-supports.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/05/why-amazon-needs.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/06/blockchain-technology-1.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/04/tie-Inflect-2018.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/04/third-wave-artificial.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/04/drug-prices-1.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/04/Can-blockchain-solve.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/04/innoplexus-uses-smart.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/04/leveraging-ai.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/04/how-blockchain.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/03/why-pharma-companies.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/03/how-artificial-intelligence.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/03/solving-big-data.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/03/machine-learning.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/08/aI-blockchain.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/02/transforming.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/01/innoplexus-strengthens.svg",
            "https://www.innoplexus.com/wp-content/uploads/2018/01/lawrence-ganti.svg",
            "https://www.innoplexus.com/wp-content/uploads/2017/07/machine-intelligence-min.svg",
            "https://www.innoplexus.com/wp-content/uploads/2017/06/accelerating-innovation.svg",
            "https://www.innoplexus.com/wp-content/uploads/2024/06/Partex-EDCC-collaboration-illustration.png",
            "https://www.innoplexus.com/wp-content/uploads/2024/04/Partex-Lupin-press-release-illustration.png",
            "https://www.innoplexus.com/wp-content/uploads/2024/03/Partex-NV-announces-collaboration-with-Althea-DRF-Lifesciences.png",
            "https://www.innoplexus.com/wp-content/uploads/2024/03/Partex-Group-presents-results-from-a-pilot-project-with-AIO.png",
            "https://www.innoplexus.com/wp-content/uploads/2024/03/Partex-Sanofi-press-release-illustration.png",
            "https://www.innoplexus.com/wp-content/uploads/2024/01/Innoplexus-AIO-partnership.png",
            "https://www.innoplexus.com/wp-content/uploads/2023/06/anavex_partex_partnership_Innoplexus.png",
            "https://www.innoplexus.com/wp-content/uploads/2023/02/Kittu-Press-Release-1.webp",
            "https://www.innoplexus.com/wp-content/uploads/2022/08/Innoplexus-Innovatrix-partnership.jpg",
            "https://www.innoplexus.com/wp-content/uploads/2022/06/Innoplexus-inflection-biosciences-joint-pr.png",
            "https://www.innoplexus.com/wp-content/uploads/2022/10/Innoplexus-Logo-white.png",
            "https://www.innoplexus.com/wp-content/uploads/2022/10/LinkedIn-icon.png",
            "https://www.innoplexus.com/wp-content/uploads/2022/10/fb-icon.png",
            "https://www.innoplexus.com/wp-content/uploads/2022/10/twitter-icon.png",
            "https://www.innoplexus.com/wp-content/uploads/2022/10/youtube-icon.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": "2022-10-18T05:07:15+00:00",
        "summary": "",
        "meta_description": "NEWS & MEDIA",
        "meta_lang": "en",
        "meta_favicon": "https://www.innoplexus.com/wp-content/uploads/2022/03/fevicon.png",
        "meta_site_name": "Innoplexus",
        "canonical_link": "https://www.innoplexus.com/news-media/",
        "text": "Partex and Singapore’s Experimental Drug Development Centre collaborate to bring\n\nFrankfurt, Germany, 3rd June 2024, 9am CET Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to…\n\nPartex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven\n\nFrankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to…\n\nPartex NV announces collaboration with Althea DRF Lifesciences to provide\n\nFrankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF…\n\nInnovative AI technology in oncology: Partex Group presents results from\n\nDuring the German Cancer Congress 2024 in Berlin, the companies Innoplexus AG /Amrit AG, companies of Partex N.V., presented the…\n\nPartex NV Forges Collaboration with Sanofi in AI-Based Dossier Enrichment\n\nFrankfurt, Germany; 14 March 2024 Partex Group, a pioneer in AI-driven drug discovery, today announces a collaboration with global pharmaceutical…\n\nInnoplexus and AIO Studien gGmbH are jointly announcing the start\n\nJanuary 02, 2024 – Innoplexus and Amrit AG, members of the Partex NV Group, providers of innovative technology for health…\n\nStrategic partnership announcement: Innoplexus holding company Partex NV is pleased\n\nExciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to announce…\n\nAI supports targeted therapy recommendations fortumor diseases – BMBF funds\n\nThe treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary…\n\nOncoCoin AG donates for a charity bicycle tour: Tour of\n\nBad Hersfeld / Germany, Aug 02, 2022– Mayor Thomas Fehling took the opportunity at the Smart City Forum, which took…\n\nInnoplexus and Innovatrix capital partner to bring about new risk-transfer\n\nArtificial Intelligence (AI) pioneer Innoplexus and London based Parametric Insurance start-up, Innovatrix Capital, collaborating upon using AI & Machine Learning…\n\nInnoplexus and Inflection Biosciences enter strategic collaboration based on Artificial\n\nInnoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence to expedite PIM kinase inhibitor development ESCHBORN, Germany, May 30,…\n\nInnoplexus and Parexel Expand Capabilities of COVID-19 Information Platform\n\nCOVID-19 Clearinghouse is the go-to platform for directly accessing the latest information and research about the coronavirus and COVID-19. ESCHBORN, Germany, Boston,…\n\nParexel and Innoplexus Unveil Single Source of COVID-19 Information for\n\nCOVID-19 Clearinghouse enables direct access to latest COVID-19 datasets, publications, research and clinical trials BOSTON and DURHAM, N.C. and ESCHBORN, Germany,…\n\nWie das „Google der Pharmaindustrie“ den Kampf gegen Corona gewinnen\n\nDie Eschborner Firma Innoplexus ist so etwas wie das Google für die Pharmaindustrie. Firmenchef Gunjan Bhardwaj erklärt, wie künstliche Intelligenz…\n\nDer Pharma-Visionär\n\nMit künstlicher Intelligenz gegen Krankheiten: Wie Gunjan Bhardwaj die Regeln der Arzneimittelforschung umschreiben will – für schnellere Ergebnisse und bessere…\n\nKünstliche Intelligenz unterstützt Suche nach Wirkstoff gegen Corona\n\nHessen fördert Forschungsprojekt mit rund 1,4 Mio. Euro. Mit einem Zuschuss von 1,4 Mio. Euro unterstützt Hessen die Entwicklung eines Wirkstoffkandidaten…\n\nNew app for cancer patients\n\nDas Eschborner Unternehmen Innoplexus hat eine neue App namens „Curia“ für Krebspatienten veröffentlicht. Mit dem Computerprogramm, das sich unentgeltlich herunterladen…\n\nRole of AI soars in tackling Covid-19 pandemic\n\nFor the first time in a pandemic, Artificial Intelligence (AI) is playing a role like never before in areas ranging…\n\nInnoplexus Announces Major Findings in Potential Combination Therapies for COVID-19\n\nDisclaimer: This press release and our findings are solely intended as information for the scientific community. This content is not intended…\n\nInnoplexus wins Silver Edison Award for OntosightⓇ Explore\n\nFrankfurt, Germany, March 26, 2020 — Innoplexus AG has been honored with the Silver Edison Award 2020 for its proprietary…\n\nInnoplexus: Big Steps to Combat the Coronavirus\n\nESCHBORN, Germany, March 18, 2020 /PRNewswire/ — The German company Innoplexus AG, also known as the “Google of the healthcare industry”…\n\nInnoplexus Opens Its Ontosight® AI Search Platform to COVID-19 Research\n\nFRANKFURT, Germany, March 15, 2020,/PRNewswire/ — Innoplexus AG has made its proprietary Ontosight® AI search platform available to medical researchers around…\n\nInnoplexus AG announces the appointment of Christian Bigatà Joseph as\n\nEschborn, 11.03.2020 – The Supervisory Board of Innoplexus AG has appointed Christian Bigatà Joseph (45) as CFO, effective as of February…\n\nInnoplexus Consulting Services is Proud to Announce ISO/IEC 27001:2013 Certification\n\nPune, India, February 13, 2020 – Innoplexus Consulting Services Private Limited, a subsidiary of Innoplexus AG, is delighted to have…\n\nCatana Capital: New collaboration with Life Science AI pioneer Innoplexus\n\nCatana Capital partners with a leading provider of AI solutions in the Life Science sector Frankfurt am Main, December 16, 2019: As…\n\nInnoplexus and Wiley partner to provide AI-powered solutions over comprehensive\n\nFrankfurt, Germany, October 15, 2019 – Innoplexus AG announces a partnership with John Wiley & Sons, Inc. (NYSE: JW-A) (NYSE:…\n\nInnoplexus and ChemAxon partner to get more out of life\n\nFrankfurt, Germany – Budapest, Hungary, September 16, 2019 – Innoplexus announces an official partnership with ChemAxon, getting the most value…\n\nInnoplexus Announces Appointment of Stratos Davlos as Chief Technology Officer\n\nHoboken, New Jersey, September 16, 2019- Innoplexus Inc., a subsidiary of Innoplexus AG, announced today the appointment of Stratos Davlos…\n\nTraum aller Anleger\n\nInnoplexus aus Eschborn und der Vermögensverwalter Acatis aus Frankfurt testen eine neue KI-Maschine für die Geldanlage. Der 21. März 2019 bleibt…\n\nInnoplexus Announces Appointment of Rita Kelley as Senior Vice President\n\nHoboken, New Jersey, September 12, 2019 – Innoplexus Inc, a subsidiary of Innoplexus AG, Frankfurt, which has developed the most…\n\nInnoplexus and Cures Within Reach for Cancer Tap the Power\n\nHoboken, NJ, August 5, 2019 – Innoplexus Holdings, Inc., a leader in artificial intelligence (AI) solutions for the life sciences…\n\nAI CTP engine estimated failure for Biogen’s aducanumab\n\nWhile drug development can be incredibly lucrative, it is a very risky business. German company Innoplexus has developed a domain-specific…\n\nPredicting Drug Flops with AI\n\nWhile drug development can be incredibly lucrative, it is a very risky business. German company Innoplexus has developed a domain-specific…\n\nGoogle for Healthcare\n\nGunjan Bhardwaj chose Germany as the place to launch his advanced search ­and discovery solution. His company assists the healthcare…\n\nLessons Learned from Other Industries\n\nWhile the auto industry is embracing big data and its opportunities for new services and deep insights, auto companies are…\n\nInnoplexus Launches Worldwide Academic Access Program for its Flagship Ontosight.ai\n\nFrankfurt, Germany, May 21, 2019 — Innoplexus announced today the launch of Ontosight Academic, a platform that provides academic researchers…\n\nInnoplexus AG wird Mitglied im Bundesverband für Künstliche Intelligenz (KI)\n\nDer am 16.3.2018 in München gegründete KI-Bundesverband verfolgt das Ziel, Deutschland als attraktiven Wirtschaftsstandort für die Weiterentwicklung von KI zu…\n\nKünstliche Intelligenz auf dem Vormarsch\n\nVeröffentlicht am 18.06.18 um 17:32 Uhr Quelle: © hessenschau Der regionale Fernsehsender Hessenschau berichtet im Rahmen der in Frankfurt am Main stattfindenden…\n\nBig Pharma setzt auf Big Data gegen die Forschungsflaute\n\nDie Digitalisierung wird zum Hoffnungsträger: Neue Analysen, Vernetzung sowie größere Datenmengen könnten der Arzneimittelentwicklung Schub geben. Frankfurt „Daten, überall Daten, aber…\n\nGoogle für die Pharmabranche\n\nInder und Schwabe Mit Freunden aus Indien hat Gunjan Bhardwaj in Deutschland Innoplexus aufgebaut – eine ausgeklügelte Suchmaschine für die Pharmabranche,…\n\nWir wollen Daten demokratisieren\n\nDr. Gunjan Bhardwaj ist Gründer und CEO der Innoplexus AG. Mit Hilfe von Künstlicher Intelligenz, Blockchain und Big-Data-Analyse-Anwendungen hat ihre…\n\nEin Gründer bekämpft Krebs mit künstlicher Intelligenz\n\nGunjan Bhardwaj hilft Pharmakonzernen, mehr über Krankheiten herauszufinden. Durch künstliche Intelligenz sollen sie schneller Medikamente entwickeln. Frankfurt. Es war ein einschneidendes…\n\n„Deutsche Tugenden sind bei KI und Deep-Tech ein Wettbewerbsvorteil“\n\nChristian Angermayer, Apeiron Investment Group, über die internationale KI-Szene, die Möglichkeiten, die sie eröffnet, und warum Deutschland das Potenzial hat,…\n\nPioniere der nächsten digitalen Revolution\n\nOb Medizin, Bankgeschäfte oder Mobilität: In Zukunft soll Künstliche Intelligenz aus dem Alltag nicht mehr wegzudenken sein. Hessische Unternehmer und…\n\nINNOPLEXUS WIEDER IM GARTNER HYPE CYCLE FÜR LIFE SCIENCES\n\nEschborn, Januar 2019. Das weltweit angesehene US-Analystenhaus Gartner Inc. veröffentlicht jährlich seinen Hype Cycle für Life Sciences, um Unternehmensvorstände zu…\n\nGoogle für die Gesundheitsbranche\n\nMit Freunden aus Indien hat Gunjan Bhardwaj in Deutschland Innoplexus aufgebaut – eine ausgeklügelte Suchmaschine für die Pharmabranche, die Profiwissen…\n\nHow can AI be leveraged for Clinical Trial Prediction?\n\nSuccessful clinical trials occur at a ratio of 1 in 10, costing around $2-$3 billion, with drugs taking 10–12 years…\n\nInnoplexus, a leading AI and Life Sciences company, raises double-digit\n\nFrankfurt, Germany – Innoplexus AG, a leading global artificial intelligence (AI) company with over 80 patent applications in AI, machine…\n\nInnoplexus’ Clinical Trial Prediction Engine predicted Aducanumab Failure\n\nFrankfurt, Germany – On March 21st, 2019, Biogen’s stock declined sharply, showing a decrease of 29%, resulting in losses to…\n\nAn AI Firm Wants to Predicts Costly Pharma Flops\n\nBefore Biogen Inc.’s experimental Alzheimer’s disease drug failed in a trial last month, analysts surveyed by Bloomberg estimated annual sales…\n\nFinger on the Pulse: GTC Spotlights Startups Propelling AI in\n\nIt can be hard to stay healthy in a convention center filled with thousands of people — unless, of course,…\n\nPharma & Healthcare Analytics Is Going To Be The Next\n\nThe Indian pharmaceutical industry has emerged as a significant contributor to the global pharmaceutical industry. As per the report by…\n\nInnoplexus: Real-Time Data Analytics to Empower Decision Making\n\nThe evolution of artificial intelligence (AI) has taken the healthcare sector by a storm promising enhanced data analytics for effective…\n\n8 Startups Ahead of the Pulse in Healthcare\n\nAI enabled healthcare is swiftly becoming today’s reality, fueled by innovative startups in the field. These startups are leveraging GPUs…\n\nBig Pharma relies on Big Data to combat the research\n\nDigitalization is becoming a source of hope: new analyses, networking, and larger amounts of data could give a boost to…\n\nPharma Outlook: 12 Trends to Watch in 2019\n\nWhat does 2019 have in store for Pharma? We asked industry Thought Leaders to name one disruptive trend or technology…\n\nMobilize data trapped in silos with Blockchain and AI\n\nThe original video was published on Talk Business 360….\n\nCan AI help in Drug Development ?\n\nThis is the talk given by Innoplexus Co-founder & CTO, Mr. Gaurav Tripathi at DataHack 2018 – an event by…\n\nThe Story Of Disrupting AI-Driven Team\n\nDiscover the story of bringing together two worlds- AI and healthcare. Gunjan Bhardwaj, Founder and CEO of Innoplexus, guides us…\n\nBuilding AI Foundation\n\nHow to build the foundations of AI your team needs?- A deep dive. Gaurav Tripathi, Co-Founder and CTO of Innoplexus,…\n\nINNOPLEXUS INCLUDED AGAIN IN GARTNER HYPE CYCLE FOR LIFE SCIENCES\n\nEschborn, January 2019. The world-renowned US analyst firm Gartner Inc. annually publishes its Hype Cycle for Life Sciences to help…\n\nHow blockchain and AI can help us decipher medicine’s big\n\nWhen diagnosed with a disease, it’s often overwhelming to sort through mountains of medical data to figure out what therapies…\n\nThe art of possibility: The talks of TED@Merck KGaA, Darmstadt,\n\nThe possibilities life affords us are endless. We can find them everywhere, at the micro and macro levels and across…\n\nAI able to ‘predict impact of minor changes’ to manufacturing\n\nIndustry 4.0 has been pitched as able to transform the way pharma manufacturing operates, Lawrence Ganti……..\n\nBlockchain in Healthcare: 6 Possible Use Cases\n\nAccording to one study, the United States healthcare system ranked last among 11 industrialized nations in terms of access, equity,…\n\n5 predictions for AI in 2019\n\nWhile several companies touted the potential of AI to disrupt the drug development industry in 2018, what practical applications can…\n\nFive AI Healthcare Startups Bringing Us Closer to Cures\n\nClinical Informatics tells us that: “Every year in the U.S., approximately 2 million patients participate in roughly 3000 clinical trials;…\n\nInnoplexus Brings Blockchain to Pharma\n\nGlobal AI firm Innoplexus launched an innovative blockchain platform to dramatically raise the amount of data available for drug research…\n\nFounder fights cancer with artificial intelligence\n\nGunjan Bhardwaj helps pharmaceutical companies to find out more about diseases. By harnessing artificial intelligence, pharmaceutical companies are able to…\n\nAI-based drug development to broaden gap between pharmaceuticals\n\nLocal pharmaceutical firms should brace for a new era where drugmakers take advantage of artificial intelligence (AI) to develop a…\n\nGoogle for Pharma\n\nIndian and Swabian Together with friends from India, Gunjan Bhardwaj has successfully launched Innoplexus, a sophisticated ecosystem of continuous analytics, powered…\n\nWe want to democratize data\n\nDr. Gunjan Bhardwaj is the founder and CEO of Innoplexus AG. With the help of artificial intelligence, blockchain and big…\n\nHow artificial intelligence impacts preventative care\n\nWith a dramatic rise in physician burnout and many physicians exiting the field prematurely, the health care industry is looking…\n\nMore transparency would bolster big pharma’s image\n\nIt’s no surprise that the public hates Big Pharma. They rank just under the government on most Americans’ despised institution…\n\nInnoplexus is working on solutions in response to GDPR and\n\nInnoplexus is at the forefront of decision-making technology as the company works in data aggregation to provide to…\n\nWhy AI and blockchain are the solutions to developing orphan\n\nWe are in the midst of a significant shift in pharmaceutical drug development, with many leading companies focusing increasingly on…\n\nWho will be the disruptor that pharma is waiting for?\n\nCompanies that thrive on sustaining products over a long period are always at risk of classic disruptive innovation—losing business to…\n\nBlockchain can take pharma collaboration and innovation to new heights\n\nThe idea that a company’s success depends on how much it can leverage the skills of its employees’ bright minds…\n\nNew Blockchain Platform from Innoplexus Will Bring Us Better, Cheaper\n\nRedundancies in any professional field mean dollars lost. But in healthcare, inefficiency can cost lives. That’s a reality that Gunjan Bhardwaj…\n\nHow Eliminating Data Silos Will Democratize Pharma R&D\n\nIn this special guest feature, Gunjan Bhardwaj, Founder and CEO of Innoplexus, discusses how data silos in pharma prevent the…\n\nWhy blockchain is a dream come true for pharma researchers\n\nResearchers tend to have a genuine scientific curiosity and desire to make the world better with their discoveries. They are…\n\nFour steps to building an innovation culture in pharma\n\nThe quest for innovation is a major driving force in pharma. From the discovery of therapeutic biologicals in the 1920s,…\n\nHow AI and Blockchain Can Help Pharma Companies Avoid Duplicative\n\n“If I have seen further than others, it is by standing upon the shoulders of giants.” – Isaac Newton There is…\n\nHow The Ethereum [ETH] Blockchain Is Powering The Next Generation\n\nAsk the average person about the blockchain, and you’d be lucky if one in ten could tell you – even…\n\nCEO and Founder Gunjan Bhardwaj, PhD On Driving Innovation and\n\nGunjan Bhardwaj is the Founder and CEO of the Innoplexus group. He was earlier with the Boston Consulting Group and…\n\nInnoplexus launches new Blockchain platform for Pharma innovation\n\nIf your loved one was diagnosed with a potentially fatal illness, wouldn’t you want all the information possible to be…\n\n3 Reasons why Innoplexus is bringing Blockchain to Pharma\n\nDon’t let the hype around blockchain fool you. Blockchain is only as useful as the solutions it provides. With all the…\n\nInnoplexus launches Blockchain platform to drive Pharma innovation\n\nResearchers can now share unpublished data securely on the blockchain Global AI company Innoplexus launched today a groundbreaking blockchain platform to…\n\nBeyond competition, Innoplexus believes in collaboration to nurture the ecosystem\n\nIn the last five years, data science has continued to make rapid advances, particularly in the fields of machine learning…\n\nGunjan Bhardwaj on “The American Dream”\n\nHosted by radio and TV personality Craig Sewing, ‘The American Dream’ is a national cable talk show that goes against…\n\nWhen should pharma execs actually care about AI?\n\nArtificial intelligence (AI) has recently garnered a lot of attention, and it is transforming the way pharma execs use their…\n\nConsumer perceptions of pharma\n\nDespite the millions of lives that are saved by pharmaceutical drugs each year, the pharmaceutical industry struggles against an enduring…\n\nHow Blockchain And AI Can Help Pharma Focus On Innovation\n\nPharmaceutical companies spend a tremendous amount of money each year on advertising and marketing. According to the Pew Charitable Trusts,…\n\nHow blockchain will revolutionize clinical trials\n\nThe risky and unpredictable nature of the clinical trial process is a major driver of high costs for pharmaceutical drugs. To…\n\nBig data, AI and social media are the changing face\n\nPharma should lean more on the power of big data and AI to identify and target individuals who possess the…\n\nHow AI And Blockchain Can Revolutionize Pharmaceutical Trials\n\nIt’s widely known by the pharmaceutical community that nearly nine out of ten drug candidates fail to win FDA approval,…\n\nTo unlock innovation, pharma needs to be honest about failure\n\nMany successful leaders agree that a company’s willingness to embrace and learn from failure can unlock innovation – and it’s…\n\nHow AI and blockchain can reduce corruption in Big Pharma\n\nGunjan Bhardwaj gives his opinion on how new technologies can help solve some of the problems in the pharma industry. The…\n\nAI and Blockchain Platform Set to Revolutionize Drug Discovery\n\nWith the burgeoning advancement and adoption of advanced technologies such as artificial intelligence in various fields, there’s hope for a…\n\nBlockchain and AI-based Platform iPlexus to Revolutionize Drug Discovery\n\nInnoplexus AG announced a revolutionary update is coming soon to their iPlexus platform that will harness the power of blockchain…\n\nGerman Blockchain, AI Platform to ‘Democratize’ Drug Development\n\nGermany-based company Innoplexus AG said that iPlexus (one of its subsidiaries) will leverage blockchain technology and AI to resolve inefficiencies…\n\nInnoplexus has been accepted to NVIDIA Inception Program\n\nInnoplexus will now be a part of NVIDIA Inception Program. A program that is designed to nurture dedicated and exceptional…\n\nIs Open Data the Silver Bullet for Better Drugs?\n\nOpen data sharing within the pharmaceutical industry is crucial for opening the floodgates of innovation. Successful innovation depends on having…\n\nNew Blockchain and AI-based Platform to Revolutionize Drug Discovery\n\nInnoplexus aims to democratize drug development with launch of new iPlexus Eschborn, Germany: Innoplexus AG announced today a groundbreaking update coming…\n\nHow Blockchain leverages the Power of Failure in Drug Development\n\n2.5 quintillion bytes of data are created every day. The challenge is to identify the relevant ones for solving a…\n\nInnoplexus’s New North American Affiliate is Bringing AI Innovation to\n\nIt’s no secret that the American pharma industry is facing its fair share of challenges. From rising drug prices to…\n\nInnoplexus Releases New Study Examining Consumer Perceptions of Pharmaceutical Companies\n\nInsights are intended to guide innovations and reforms within the industry Hoboken, New Jersey: Innoplexus, a leader in artificial intelligence and…\n\nInnoplexus supports the European Summer School in Logic, Language and\n\nIn late 90s, internet solved the problem of data access. Then came the explosion of data with the web search…\n\nInnoplexus Announces New North American Affiliate Helmed by Former Merck\n\nLeader in Pharmaceutical Research AI expands North American Presence. HOBOKEN, NJ, May 10, 2018 /24-7PressRelease/ — Innoplexus, a leader in artificial intelligence and data…\n\nInnoplexus supports the WHO “Save Lives – Clean Your Hands”\n\nEschborn, 5th May 2018 – Innoplexus AG supports the World Health Organization (WHO) and the Global Sepsis Alliance (GSA) by…\n\nWhy Amazon Needs AI At The Center Of Its Healthcare\n\nPost Written ByGunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of Innoplexus AG. In December 2017, Amazon, JPMorgan Chase…\n\nFive use cases for blockchain in pharma Pharmaphorum\n\nAs blockchain expands its reach across different industries, Gunjan Bhardwaj examines some of its practical applications in the pharma industry. Blockchain…\n\nTiE Inflect 2018 announces Innoplexus AG as a 2018 TiE50 Finalist\n\nApril 23, 2018 – Eschborn – Innoplexus AG is excited to announce that it has been selected as a “2018 TiE50…\n\nThird Wave of Artificial intelligence promises the first AI Summit organised\n\nInsights into the Third Wave of Artificial intelligence promises the first AI Summit organised by Innoplexus and Frankfurt School of Finance…\n\nDrug Prices Are Too Expensive: Here’s How Technology Can Fix\n\nPost Written ByGunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of Innoplexus AG. The cost of drug development has…\n\nCan blockchain solve pharma’s counterfeit drug problem? Pharmaphorum\n\nNobody doubts that fake medicines are an increasing threat to consumers and the pharma industry’s bottom line. Is blockchain the…\n\nHow Innoplexus uses smart and on-edge technology to help its\n\nWhen a major global pharmaceutical company wanted to accelerate the development of a new therapy line and discover how to…\n\nLeveraging AI and Blockchain to Transform Healthcare\n\nMedicine is ripe for disruption. As David Lawrence, former Chairman and CEO of the Kaiser Foundation Health Plan, wrote in his…\n\nHow Blockchain Can Improve the Pharma Manufacturing Supply Chain Pharmaphorum\n\nThe entire pharmaceutical industry has been booming, from the manufacturing of clinical trial materials to support research studies to the…\n\nWhy pharma companies need to upgrade their intelligence Pharmaphorum\n\nIn the 21st century pharma companies face novel challenges. Pairing artificial intelligence (AI) capabilities with human strengths can bring a…\n\nHow artificial intelligence powers healthcare innovation Digital Commerce 360\n\nWhen medicine incorporates AI, blockchain, and big data we are going to lower costs, reduce health disparity, and speed novel…\n\nSolving the Big Data problem in pharma innovation Pharmaphorum\n\nThe effectiveness of AI applications can be undermined by the volumes of unstructured data prevalent in the pharma industry. What…\n\nUsing AI & Machine Learning, Indo-German company Innoplexus is helping\n\nMaking more people aware about clinical trials that identify data patterns on usage of a particular drug to discover if it can…\n\nHow AI, blockchain, and big data can reduce drug development\n\nCutting-edge technologies are increasingly improving pharma’s R&D processes, which will reduce costs and, in turn, benefit patients, says Gunjan Bhardwaj. It’s…\n\nHow AI Is Transforming The Future Of Healthcare\n\nPost Written ByGunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of Innoplexus AG. I recently wrote about five technologies…\n\nInnoplexus strengthens its global leadership team with accomplished leaders- appoints\n\nInnoplexus AG, a leading AI based analytics as a service provider in life sciences and financial services domain, announced today…\n\nGaining Momentum: Ex – President, Merck KGaA (Latin America), Lawrence\n\nInnoplexus AG, a leading AI based analytics as a service provider in life sciences and financial services domain, announced today…\n\nInnoplexus @ Machine Intelligence Summit, Berlin 2017\n\nInnoplexus AG proudly announces that our founder and CEO, Dr Gunjan Bhardwaj will be on the panel discussion at Machine…"
    }
}